Recs

0
Player Avatar rockambo (< 20) Submitted: 12/5/2008 1:36:48 PM : Underperform Start Price: $13.94 PFE Score: +12.00

so lots of good things are happen to this company, but they haven't recovered from the blockbuster business model and there's about one potential drug in the pipeline and a whole lot of expiring patents. Longterm I see growth, shortterm, lots of pain medication and suffering.

Report this Post Add Comment

Featured Broker Partners


Advertisement